ライフサイエンスコーパス: cardiometabolic risk factor

1 ceral adiposity, is emerging as a recognized cardiometabolic risk factor.

2 y), and 70% of the children had at least one cardiometabolic risk factor.

3 asured by whole-body MRI after adjusting for cardiometabolic risk factors.

4 y in the absence of the associated burden of cardiometabolic risk factors.

5 imate the effect of environmental factors on cardiometabolic risk factors.

6 significant weight loss and improvements in cardiometabolic risk factors.

7 expenditure (REE), satiety and appetite, and cardiometabolic risk factors.

8 vascular risk, independently of conventional cardiometabolic risk factors.

9 mine the effect of low AGE diets in reducing cardiometabolic risk factors.

10 white rice by substituting beans, may lower cardiometabolic risk factors.

11 25(OH)D and prevalence of MetSyn and several cardiometabolic risk factors.

12 he associations between urban life-years and cardiometabolic risk factors.

13 ce, and sugar-sweetened beverages (SSBs) and cardiometabolic risk factors.

14 a key independent role in the modulation of cardiometabolic risk factors.

15 ificant weight loss and favorable changes in cardiometabolic risk factors.

16 explained, at most, 8% of the variability in cardiometabolic risk factors.

17 eatment Panel III definition) and individual cardiometabolic risk factors.

18 strongest correlations between VAT area and cardiometabolic risk factors.

19 d their weight loss and favorable changes in cardiometabolic risk factors.

20 waist circumference and favorable changes in cardiometabolic risk factors.

21 ircumference, plasma lipid levels, and other cardiometabolic risk factors.

22 ignificant effects on several other nonlipid cardiometabolic risk factors.

23 p bridge the equity gap in the management of cardiometabolic risk factors.

24 ffects of n-3 (omega-3) fatty acids (FAs) on cardiometabolic risk factors.

25 rts higher-protein diets for improvements in cardiometabolic risk factors.

26 Olive oil has been shown to improve various cardiometabolic risk factors.

27 All analyses were adjusted for cardiometabolic risk factors.

28 , adjusting for demographic, behavioral, and cardiometabolic risk factors.

29 .9 mg/dL}]) (17 studies), and improved other cardiometabolic risk factors.

30 tem with food-group and nutrient intakes and cardiometabolic risk factors.

31 for demographic, diet, lifestyle, and other cardiometabolic risk factors.

32 levels of SDMA, AGXT2 variants, and various cardiometabolic risk factors.

33 urements included changes in body weight and cardiometabolic risk factors.

34 olescent females, AMH is not associated with cardiometabolic risk factors.

35 ETC-1002 may have favorable effects on other cardiometabolic risk factors.

36 oth groups underwent intensive management of cardiometabolic risk factors.

37 impairment and is not confounded by various cardiometabolic risk factors.

38 s in treating hypercholesterolemia and other cardiometabolic risk factors.

39 rtant reductions in body weight and improved cardiometabolic risk factors.

40 r the identification of adults with elevated cardiometabolic risk factors.

41 gh 2012 to assess the prevalence of multiple cardiometabolic risk factors according to the severity o

42 r levels of MVPA were associated with better cardiometabolic risk factors across tertiles of sedentar

43 advantage, perceived neighborhood safety and cardiometabolic risk factors, adjusting for health behav

44 Measurements were also made of the cardiometabolic risk factors age, systolic blood pressur

45 Retrospectively, we analysed trajectories of cardiometabolic risk factors and 10 year cardiovascular

46 In patients with FES, cardiometabolic risk factors and abnormalities are prese

47 Associations among cardiometabolic risk factors and BMI and WC were evaluat

48 This study examined prepregnancy cardiometabolic risk factors and gestational diabetes me

49 diet was associated with improvement in some cardiometabolic risk factors and greater reduction in ad

50 tem that reduces NCD risk factors, including cardiometabolic risk factors and infections that are pre

51 re few therapeutic recommendations for these cardiometabolic risk factors and little evidence of thei

52 However, we observed different changes in cardiometabolic risk factors and nutritional markers bet

53 We examined cardiometabolic risk factors and pathways associated wit

54 The authors measured prepregnancy cardiometabolic risk factors and performed multivariate

55 abolites have differential associations with cardiometabolic risk factors and subtypes of vascular di

56 Studies showed improvements in cardiometabolic risk factors and, in several, androgen e

57 d to determine associations between Lp-PLA2, cardiometabolic risk factors, and subclinical atheroscle

58 anges in body weight, coexisting conditions, cardiometabolic risk factors, and weight-related quality

59 LDL-C (primary endpoint), other lipids, and cardiometabolic risk factors; and safety.

60 associations between infant growth and adult cardiometabolic risk factors (anthropometric characteris

61 on of vitamin D supplementation in reversing cardiometabolic risk factors appears to be warranted.

62 verse associations between abdominal SAT and cardiometabolic risk factors are attenuated and, in the

63 d-effects models to estimate mean changes in cardiometabolic risk factors associated with changes in

64 insulin resistance, dyslipidemia, and other cardiometabolic risk factors associated with NAFLD.

65 of change in body mass index (BMI) and other cardiometabolic risk factors before type 2 diabetes diag

66 SSB intakes are associated with increases in cardiometabolic risk factors between 14 and 17 y of age.

67 aist circumference, fat, and lean mass), and cardiometabolic risk factors (blood pressure and fasting

68 during childhood (up to 18 years of age) and cardiometabolic risk factors (body mass index, fat mass

69 h temporal changes in 3 objectively measured cardiometabolic risk factors: body mass index, systolic

70 d with level of alanine aminotransferase and cardiometabolic risk factors, but not body mass index.

71 ty, several chronic diseases, and a range of cardiometabolic risk factors, but there is no convincing

72 ildhood adiposity is associated with adverse cardiometabolic risk factors, but with no evidence of va

73 egated pre- and post-intervention weight and cardiometabolic risk factor changes (fasting blood gluco

74 No prior analyses have aggregated weight and cardiometabolic risk factor changes observed in studies

75 loss and sustained improvements in HbA1c and cardiometabolic risk factors compared with medical manag

76 Among overweight women, 26.7% with 1 or more cardiometabolic risk factors developed GDM versus 7.4% w

77 mediated by related comorbidities, including cardiometabolic risk factors (diabetes mellitus, hyperte

78 lely to increased body weight and associated cardiometabolic risk factors (e.g.,dyslipidemia or hyper

79 moves to an urban environment, whereas other cardiometabolic risk factors evolve gradually.

80 Sociodemographic, behavioural, and cardiometabolic risk factors from 1985 and chronic condi

81 ans, yet the combined role of these foods on cardiometabolic risk factors has not been studied.

82 to examine relations of plasma measures with cardiometabolic risk factors, history of cardiovascular

83 a choline and choline-related compounds with cardiometabolic risk factors, history of cardiovascular

84 Regular exercise improves many cardiometabolic risks factors; however, its effect on in

85 the relations between obesity indicators and cardiometabolic risk factors in 324 Chilean children 4 y

86 med to assess whether AMH is associated with cardiometabolic risk factors in a general population of

87 ssociated with abdominal adiposity and other cardiometabolic risk factors in a sample of women 4-12 y

88 trajectories of insulin resistance and other cardiometabolic risk factors in a white, British populat

89 ese maternal attributes are related to other cardiometabolic risk factors in adulthood has not been c

90 SAT area on subclinical atherosclerosis and cardiometabolic risk factors in both whites and African

91 among healthy term infants did not influence cardiometabolic risk factors in childhood.

92 eased duration of exclusive breastfeeding on cardiometabolic risk factors in childhood.

93 sical activity with individual and clustered cardiometabolic risk factors in healthy children aged 10

94 en physical activity and sedentary time with cardiometabolic risk factors in healthy children.

95 There were also significant improvements in cardiometabolic risk factors in intervention compared wi

96 and the more potent association of VFA with cardiometabolic risk factors in men and women with RA, m

97 blocker, may reduce body weight and improve cardiometabolic risk factors in patients who are overwei

98 decreasing diabetes incidence and improving cardiometabolic risk factors in persons at increased ris

99 o examine the prevalence of diabetes-related cardiometabolic risk factors in this large, but little-s

100 The relation between serum 25(OH)D and cardiometabolic risk factors in US children was investig

101 lunch with that at dinner on weight loss and cardiometabolic risk factors in women during a weight-lo

102 ith LF yogurt consumption on body weight and cardiometabolic risk factors in women during a weight-lo

103 fore and during pregnancy is associated with cardiometabolic risk factors in young adult offspring.

104 We investigated cardiometabolic risk factors in young adults who were bo

105 ubcomponent of physical activity may predict cardiometabolic risk factors in youths.We examined the i

106 al amounts of SFAs from cheese and butter on cardiometabolic risk factors.In a multicenter, crossover

107 LSG can significantly improve cardiometabolic risk factors including glycemic status i

108 Continuous AsIII exposure increased cardiometabolic risk factors including increased body we

109 haled CO was associated with the presence of cardiometabolic risk factors (including smoking) and pre

110 eing developed for the treatment of multiple cardiometabolic risk factors, including abdominal obesit

111 havior modification in treatment of multiple cardiometabolic risk factors, including abdominal obesit

112 se migrant workers had none of the following cardiometabolic risk factors, including current cigarett

113 syndrome (MetS) refers to the clustering of cardiometabolic risk factors, including dyslipidemia, ce

114 Cardiometabolic risk factors, including fatty liver, are

115 djustment for longstanding illness and major cardiometabolic risk factors indicated that disease proc

116 e observed polygenic overlap between CAD and cardiometabolic risk factors indicates a pathogenic rela

117 iations of Anti-Mullerian hormone (AMH) with cardiometabolic risk factors is lacking.

118 Although the prevalence of cardiometabolic risk factors is relatively low among chi

119 children with increased WHtRs have abnormal cardiometabolic risk factor levels.

120 Whether weight reduction and cardiometabolic risk factor management can reduce the bu

121 asions could lead to healthier lifestyle and cardiometabolic risk factor management.

122 Secondary outcomes were cardiometabolic risk factors, nutritional outcomes, adve

123 that sensitize the genome to these and other cardiometabolic risk factors of the diabetic milieu are

124 Effect modification by pre-existing cardiometabolic risk factors on the PM2.5-CVD mortality

125 as not associated with any of the individual cardiometabolic risk factors or clustered cardiometaboli

126 vements in appetite, body weight management, cardiometabolic risk factors, or all of these health out

127 ood foreclosures had mixed associations with cardiometabolic risk factors over time.

128 n, and most of the children had at least one cardiometabolic risk factor, particularly lipid disorder

129 s associated with an increased prevalence of cardiometabolic risk factors, particularly among boys an

130 ted with characteristics of both a favorable cardiometabolic risk-factor profile (higher HDL choleste

131 choline were associated with an unfavorable cardiometabolic risk-factor profile [lower high-density

132 sma betaine were associated with a favorable cardiometabolic risk-factor profile [lower low-density l

133 outcomes including anthropometric measures, cardiometabolic risk factors, pulmonary function, vitami

134 d hypertensive, with increased prevalence of cardiometabolic risk factors regardless of BMI.

135 )D was significantly associated with several cardiometabolic risk factors regardless of obesity.

136 n and adolescents was associated with better cardiometabolic risk factors regardless of the amount of

137 had a high prevalence of cardiovascular and cardiometabolic risk factors, similar to patients with t

138 HS exposure is associated with clustering of cardiometabolic risk factors such as obesity, dyslipidem

139 Cardiometabolic risk factors such as obesity, excess per

140 cations produce greater improvements in many cardiometabolic risk factors than placebo, but no obesit

141 verse relation between physical activity and cardiometabolic risk factors that is independent of sede

142 y reported associations between 25(OH)D with cardiometabolic risk factors using data from NHANES were

143 intake, energy intake, nutrient intake, and cardiometabolic risk factors was analyzed in 11,296 men

144 Cardiometabolic risk factors were assessed in 240 twin p

145 tions of parental separation with children's cardiometabolic risk factors were largely null.

146 d with the general population in China, most cardiometabolic risk factors were less prevalent in migr

147 ith a serious mental illness and one or more cardiometabolic risk factors were randomly assigned to e

148 Associated trajectories of cardiometabolic risk factors were studied using adjusted

149 10-y interval that included measurements of cardiometabolic risk factors, were included in the study